Breadcrumb Navigation

Third Zurich Precision-Oncology Symposium

Fast-evolving treatment options and emerging technologies continue to advance the field of Precision Oncology.

Maskenpflicht und Händehygiene
Bei Kursen, Kongressen und Vorlesungen in USZ-Räumen gilt eine Maskenpflicht und Händehygiene. Die Zertifikatspflicht für Besucherinnen und Besucher entfällt.

Standort

Virtual event

Datum

03.03.2022

Uhrzeit

3.00 - 7.15 pm

Credits

4 SGMO

3rd Zurich Precision-Oncology Symposium

3:29:57

The 3nd Precision Oncology Symposium of the Comprehensive Cancer Center Zurich will bring together oncologists, cancer scientists and data experts to discuss latest developments and future directions of targeted treatment strategies.

Program

3.00 pm Welcome
Andreas Wicki, University Hospital
Christian Britschgi, University Hospital Zurich
3.05 pm Targeted therapies NSCLC – implications for comprehensive treatment strategy
Rafał Dziadziuszko, Department of Oncology and Radiotherapy of the Medical University
of Gdansk, Poland
3.35 pm Melanoma therapy: precision approaches are essential
Reinhard Dummer, University Hospital Zurich
4.05 pm Chances and challenges – precision in GI Oncology
Florian Lordick, University Hospital Leipzig
4.35 pm Spatial biology in intestinal homeostasis and cancer
Andreas Moor, ETH Zurich
5.05 pm Break
5.35 pm Biology and Vulnerabilities of Circulating Tumor Cells
Nicola Acetto, ETH Zurich
6.05 pm Identifying combination therapies with functional precision medicine
Anthony G. Letai, Dana-Farber Cancer Institute, Boston
6.35 pm A national precision cancer medicine implementation initiative: Prototype learning ecosystem for precision oncology
Kjetil Tasken, Oslo University Hospital, Norway
7.05 pm Wrap-up
Andreas Wicki, University Hospital
Christian Britschgi, University Hospital Zurich

Verantwortlicher Fachbereich

Comprehensive Cancer Center Zürich